Neptune Medical earns FDA clearance for its Triton 1 robotic system

Neptune Medical announced FDA clearance for its Triton 1 robotic endoscopic system for diagnosis and treatment throughout the colon. In the CARE 1 study, the system achieved 100% cecal intubation, no adverse events, and an adenoma detection rate of 54.2% versus the industry threshold of 35%.

• FDA cleared the Triton 1 robotic system for colonoscopy
• In CARE 1 study: 100% cecal intubation with no adverse events
• Adenoma detection rate 54.2% versus industry threshold of 35%
• Physician workload 67% lower than with manual colonoscopy